Paper26344626
Therapeutic Vaccine Strategies against Human Papillomavirus.
Khallouf H and 2 others. Vaccines (Basel), 2014. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic Vaccine Strategies against Human Papillomavirus. Papers, record 26344626. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344626
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References210
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14975189 | Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity. | Hum Gene Ther | 2004 | https://conductscience.org/library/papers/14975189 | PubMed |
| 2 | 23557172 | HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. | J Transl Med | 2013 | https://conductscience.org/library/papers/23557172 | PubMed |
| 3 | 17473845 | More than one reason to rethink the use of peptides in vaccine design. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17473845 | PubMed |
| 4 | 10999722 | A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10999722 | PubMed |
| 5 | 16288373 | Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. | J Infect Dis | 2005 | https://conductscience.org/library/papers/16288373 | PubMed |
| 6 | 21514130 | Viral vectors as vaccine platforms: deployment in sight. | Curr Opin Immunol | 2011 | https://conductscience.org/library/papers/21514130 | PubMed |
| 7 | 24485523 | Orchestrating immune check-point blockade for cancer immunotherapy in combinations. | Curr Opin Immunol | 2014 | https://conductscience.org/library/papers/24485523 | PubMed |
| 8 | 21029962 | Systems vaccinology. | Immunity | 2010 | https://conductscience.org/library/papers/21029962 | PubMed |
| 9 | 22700466 | Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein. | Int J Cancer | 2013 | https://conductscience.org/library/papers/22700466 | PubMed |
| 10 | 11342644 | Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. | J Immunol | 2001 | https://conductscience.org/library/papers/11342644 | PubMed |
| 11 | 21220591 | Human papillomaviruses as therapeutic targets in human cancer. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21220591 | PubMed |
| 12 | 12559783 | Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7. | Vaccine | 2003 | https://conductscience.org/library/papers/12559783 | PubMed |
| 13 | 24007495 | Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors. | Hum Gene Ther | 2013 | https://conductscience.org/library/papers/24007495 | PubMed |
| 14 | 10746552 | Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma. | J Immunother | 2000 | https://conductscience.org/library/papers/10746552 | PubMed |
| 15 | 22051890 | Vaccines for the twenty-first century society. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/22051890 | PubMed |
| 16 | 21772284 | Solving vaccine mysteries: a systems biology perspective. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21772284 | PubMed |
| 17 | 15131030 | Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15131030 | PubMed |
| 18 | 23994536 | Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape. | Gynecol Oncol | 2013 | https://conductscience.org/library/papers/23994536 | PubMed |
| 19 | 21748025 | Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial. | ISRN Obstet Gynecol | 2011 | https://conductscience.org/library/papers/21748025 | PubMed |
| 20 | 15665308 | Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. | Cancer Res | 2005 | https://conductscience.org/library/papers/15665308 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41901718 | The Exploration of Therapeutic Antivirals for Human Papillomavirus in the Last 40 Years: Bibliometric Research. | Pathogens | 2026 | https://conductscience.org/library/papers/41901718 | PubMed |
| 41667914 | Precision management of cervical cancer emphasizes immunotherapy combination regimens and translational advances. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41667914 | PubMed |
| 41487403 | Molecular mechanisms of human papillomavirus-induced tongue carcinogenesis: A systematic review. | J Oral Biol Craniofac Res | 2026 | https://conductscience.org/library/papers/41487403 | PubMed |
| 40619783 | Human papillomavirus vaccine: Success and challenges. | J Biosci | 2025 | https://conductscience.org/library/papers/40619783 | PubMed |
| 40589751 | Immune responses to human papillomavirus infection and vaccination. | Front Immunol | 2025 | https://conductscience.org/library/papers/40589751 | PubMed |
| 40282913 | Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma Cauterization. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40282913 | PubMed |
| 39453911 | Design and antiviral assessment of a panel of fusion proteins targeting human papillomavirus type 16. | PLoS One | 2024 | https://conductscience.org/library/papers/39453911 | PubMed |
| 39339987 | Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39339987 | PubMed |
| 39280196 | Primary Prevention in Cervical Cancer-Current Status and Way Forward. | J Obstet Gynaecol India | 2024 | https://conductscience.org/library/papers/39280196 | PubMed |
| 38983849 | Current status and future directions for the development of human papillomavirus vaccines. | Front Immunol | 2024 | https://conductscience.org/library/papers/38983849 | PubMed |
| 38605958 | Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study. | Front Immunol | 2024 | https://conductscience.org/library/papers/38605958 | PubMed |
| 37600773 | Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies. | Front Immunol | 2023 | https://conductscience.org/library/papers/37600773 | PubMed |
| 36146843 | Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses. | Viruses | 2022 | https://conductscience.org/library/papers/36146843 | PubMed |
| 34642315 | Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/34642315 | PubMed |
| 33976146 | Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic. | Nat Commun | 2021 | https://conductscience.org/library/papers/33976146 | PubMed |
| 32934952 | HSV-TK Expressing Mesenchymal Stem Cells Exert Inhibitory Effect on Cervical Cancer Model. | Int J Mol Cell Med | 2020 | https://conductscience.org/library/papers/32934952 | PubMed |
| 32922389 | Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations. | Front Immunol | 2020 | https://conductscience.org/library/papers/32922389 | PubMed |
| 32837456 | HPV16-E7 Protein T Cell Epitope Prediction and Global Therapeutic Peptide Vaccine Design Based on Human Leukocyte Antigen Frequency: An In-Silico Study. | Int J Pept Res Ther | 2021 | https://conductscience.org/library/papers/32837456 | PubMed |
| 32404527 | Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors. | J Virol | 2020 | https://conductscience.org/library/papers/32404527 | PubMed |
| 31948126 | Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer. | J Clin Med | 2020 | https://conductscience.org/library/papers/31948126 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26344626
GET https://conductscience.org/api/papers/v1/26344626/references?page=2